Lanzamiento Enero 2027

Revisión sistemática2019

Effects of blueberry and cranberry consumption on type 2 diabetes glycemic control: A systematic review

Rocha DMUP, Caldas APS, da Silva BP, Hermsdorff HHM, Alfenas RCG

Critical reviews in food science and nutrition · 40 citas

Cómo se estudió

Diseño
Revisión sistemática (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación independiente
Gobierno
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Gobierno
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Gobierno
Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Gobierno
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Gobierno
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Gobierno
Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Según 6 financiadores declarados.

Publicación

Publicado
2018-01-18 · Crit Rev Food Sci Nutr · vol. 59 · número 11 · págs. 1816–1828
Editorial
Taylor & Francis
Citado
67 citas · más que el 87% de estudios similares · 1.8× el promedio de su campo
Referencias
74 trabajos
Acceso
De pago
Áreas de investigación
Natural Antidiabetic Agents Studies · Phytochemicals and Antioxidant Activities · Diet, Metabolism, and Disease
Palabras clave
Glycemic, Type 2 diabetes, Diabetes mellitus, Medicine, Food science, Sweetening agents, Chemistry, Endocrinology
MeSH
animals, humans, vaccinium macrocarpon, fruit, diabetes mellitus, type 2, anthocyanins, blood glucose, plant extracts, complementary therapies, phytotherapy, dietary supplements, databases, factual, randomized controlled trials as topic, polyphenols, blueberry plants

5 autores

  • Daniela Mayumi Usuda Prado Rocha🇧🇷 · autor de correspondenciaUniversidade Federal de Viçosa
  • Ana Paula Silva Caldas🇧🇷Universidade Federal de Viçosa
  • Bárbara Pereira da Silva🇧🇷Universidade Federal de Viçosa
  • Helen Hermana Miranda Hermsdorff🇧🇷Universidade Federal de Viçosa
  • Rita de Cássia Gonçalves Alfenas🇧🇷Universidade Federal de Viçosa

Resumen

El texto original del estudio, en el idioma en que se publicó.

The metabolic effects of cranberry and blueberry consumption on glycemic control have been evaluated in vitro and in animal models as well as in human studies, although findings have not been systematically reviewed yet. Therefore, a systematic review was carried out of relevant randomized clinical trials (RCTs) in order to assess the effect of berries (blueberry and cranberry) consumption on type 2 diabetes (T2DM) glycemic control. Some evidences were also discussed on the anti-diabetic mechanisms exerted by berries polyphenols. Studies were identified by searching electronic databases: LILACS, PubMed/MEDLINE, Scopus, The Cochrane Library and Web of Science. Three authors independently searched and extracted RCTs in which the effect of berries (cranberry or blueberry) consumption on T2DM glycemic control was assessed. A total of 7 RCTs, involving 270 adults with type 2 diabetes were included. Despite the heterogeneity of the administration forms (in natura, dried, extract, preparations - juice), dosage, duration of the intervention and type of population of the studies involving these two berries some studies highlight the potential benefit of berries, especially of blueberry, on glucose metabolism in T2DM subjects. Daily cranberry juice (240 mL) consumption for 12 weeks and blueberry extract or powder supplementation (9.1 to 9.8 mg of anthocyanins, respectively) for 8 to 12 weeks showed a beneficial effect on glucose control in T2DM subjects. Those results indicate a promising use of these berries in T2DM management; although more studies are required to better understand the mechanisms involved.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.